Bold
Investors
ASX
Latest News
ASX Announcements
Companies
Home
ASX Announcements
ATH Announcements
Alterity Receives Positive FDA Feedback…
ATH
ALTERITY THERAPEUTICS LIMITED
Market sensitive
Alterity Receives Positive FDA Feedback on CMC Meeting
Date and time
27 April 2026 at 6:56 pm
Announcement type
Company Update
Show details
Hide details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASX
Open original PDF
ATH announcement history
Recent ATH announcements
Application for quotation of securities - ATH
Disclosure Under Takeovers Panel GN 20
Application for quotation of securities - ATH
Granted New U.S. Composition of Matter Patent for ATH434
Application for quotation of securities - ATH
Alterity to Present at Canaccord Genuity Growth Conference